Stephen Mayo Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Stephen Mayo is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 6,621 shares of SRPT, which is worth approximately $756,912. The most recent transaction as insider was on Mar 05, 2024, when has been sold 3,135 shares (Common Stock) at a price of $122.96 per share, resulting in proceeds of $385,479. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.62K
0% 3M change
16.3% 12M change
Total Value Held $756,912

Stephen Mayo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2024
SELL
Open market or private sale
$385,479 $122.96 p/Share
3,135 Reduced 32.13%
6,621 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
1,846 Added 15.91%
9,756 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
1,523 Added 16.15%
7,910 Common Stock
Nov 17 2022
SELL
Open market or private sale
$94,311 $109.92 p/Share
858 Reduced 11.84%
6,387 Common Stock
Mar 07 2022
BUY
Grant, award, or other acquisition
-
2,953 Added 28.96%
7,245 Common Stock
Nov 16 2021
BUY
Grant, award, or other acquisition
-
4,292 Added 50.0%
4,292 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
Director
ALLO
Allogene Therapeutics, Inc. Healthcare
SM

Stephen Mayo

Rahway, NJ

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT